Author

Rob E. Carpenter

The University of Texas at TylerORCID 0000-0002-2818-7474Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genomics· 2 Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:variant calling· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Organism:human· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Vaibhav Kumar TamrakariD· 3 shared Rahul SharmaiD· 2 shared Sadia AlmasiD· 2 shared Chase Rowan· 1 shared Emily BrowniD· 1 shared Harendra ChahariD· 1 shared Rahul SharmaiD· 1 shared Tyler VineiD· 1 shared

Activity by Year

2022-2022 · peak 3/yr

Co-Author Collaboration Network

8 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenomics

Vaibhav Kumar TamrakarORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Optimization of the Illumina COVIDSeq™ protocol for decentralized, cost-effective genomic surveillance

Rob E. Carpenter, Vaibhav Kumar Tamrakar, Sadia Almas, Chase Rowan, Rahul Sharma

The paper optimizes the Illumina COVIDSeq protocol to reduce costs while maintaining accuracy for decentralized SARS-CoV-2 genomic surveillance.

bioRxiv · Nov 7, 2022 · PreprintGenomics

Confirming Multiplex Q-PCR Use in COVID-19 with Next Generation Sequencing: Strategies for Epidemiological Advantage

Rob E. Carpenter, Vaibhav Kumar Tamrakar, Harendra Chahar, Tyler Vine, Rahul Sharma

This study compares Q-PCR and NGS for detecting SARS-CoV-2 variants, showing Q-PCR's effectiveness for screening known mutations in a cost-effective manner.

bioRxiv · Feb 22, 2022 · PreprintGenomics

COVID Seq as Laboratory Developed Test (LDT) for diagnosis of SARS-CoV-2 Variants of Concern (VOC)

Rob E. Carpenter, Vaibhav Kumar Tamrakar, Sadia Almas, Emily Brown, Rahul Sharma

The paper validates the Illumina COVID-Seq assay as a laboratory-developed test for detecting SARS-CoV-2 variants with high specificity and accuracy.

Archives of Clinical and Biomedical Research · Jan 1, 2022Peer-reviewedGenetic & Genomic Medicine